US2003195140A1PendingUtilityA1
Methods and compositions for improving sleep
Assignee: VAXIS THERAPEUTICS CORP NOW CEPriority: Feb 22, 2000Filed: Mar 11, 2003Published: Oct 16, 2003
Est. expiryFeb 22, 2020(expired)· nominal 20-yr term from priority
A61K 45/06A61K 31/535A61K 9/7023A61P 25/20A61K 31/21A61K 31/455A61K 31/34A61K 45/00
51
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods and compositions for improving sleep in individuals with sleep disorders or other conditions which interfere with normal sleep via administration of a NO-mimetic are provided.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method for improving sleep in an individual suffering from a sleep disorder or a condition wherein normal sleep is interrupted or interfered with, said method comprising administering to the individual a NO-mimetic in an amount therapeutically effective to improve sleep in the individual.
2 . The method of claim 1 wherein the amount of NO-mimetic administered is less than an amount effective to appreciably alter systemic vascular tone.
3 . The method of claim 2 where the amount of NO-mimetic administered is one half to one fortieth of the amount of NO-mimetic known to appreciably alter systemic vascular tone in normal circulation in a human.
4 . The method of claim 1 , wherein the NO-mimetic is administered by transdermal patch.
5 . The method of claim 1 wherein the NO-mimetic is co-administered with an established drug for sleep disorders or a condition wherein normal sleep is interrupted or interfered with.
6 . A method for decreasing a therapeutic dosage of an established drug for sleep disorders or a condition wherein normal sleep is interrupted or interfered with, said method comprising co-administering the established drug with a NO-mimetic.
7 . A pharmaceutical composition comprising a NO-mimetic and an established drug for sleep disorders or a condition wherein normal sleep is interrupted or interfered with.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.